Search results
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 2 days agoThe stock price of Moderna has seen a sharp 27% rise in a month, while its peer – BioNTech – has...
Forbes Daily: Warren Buffett’s Fortune Drops As Berkshire Stock Slumps
Forbes· 4 days agoMany of us spend our working years with the goal of retiring, but there are a number of reasons why...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
Reuters· 4 days agoCOVID-19 vaccine makers said data from animals studies showed their 2024-25 shots targeting the JN.1...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
KEYT 3 Santa Barbara· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
WSAU Wausau· 4 days ago(Reuters) - COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via Yahoo News· 2 days agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
What the EU Has Done for Us | by Nadia Calviño - Project Syndicate
Project Syndicate· 5 days agoThis week, hundreds of millions of voters will head to the polls for the European Parliament...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News· 4 days ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 3 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Analysis | Biden wants hospitals to report data on gunshot wounds
Washington Post· 3 days agoToday’s edition: Doctors are urging the federal government to probe whether the coronavirus can...